ClinicalTrials.Veeva

Menu

A Realworld Study of Acute Respiratory Distress Syndrome in China (CHARDSnet)

C

China-Japan Friendship Hospital

Status

Unknown

Conditions

Acute Respiratory Distress Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT02975908
CHARDS20160301

Details and patient eligibility

About

ARDS is a critical respiratory disease caused by endogenous and exogenous factors. The mortality of ARDS varies from 30 to 70%. In 2012, a new international diagnostic criterion has been put forward. Yet, its feasibility, reliability and validity need to be tested. Meanwhile, the correlation of different severity and prognosis remains unclear. As so far, the epidemiological information about ARDS in China is lacking.

Investigators plan to conduct a multi-center observational study(real-life study) to investigate the risk factors, morbidity, management and prognosis of ARDS in China, in order to facilitate standardization of diagnosis and management of ARDS and provide basic data and idea for further clinical intervention studies.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years of age; hospitalized patients with main diagnosis as ARDS.

Exclusion criteria

  • <18 years of age
  • Patients or their families refused to participate in the study
  • Patients diagnosed as COPD, pulmonary fibrosis or bronchiectasis

Trial contacts and locations

1

Loading...

Central trial contact

Huang Xu; Zhan Qingyuan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems